FTC approves final order resolving competition concerns regarding Novartis, GSK joint venture
MLex Summary: The US Federal Trade Commission has approved a final order settling charges that Novartis’ consumer health care products joint venture with GlaxoSmithKline would likely be anticompetitive. Under the order, Novartis...To view the full article, register now.
Already a subscriber? Click here to view full article